Boehringer Blocked From Making False GSK Inhaler Claims
A Pennsylvania federal judge on Thursday issued a preliminary injunction blocking Boehringer Ingelheim Pharmaceuticals from conveying in training materials for its sales representatives false or misleading information about rival GlaxoSmithKline LLC's...To view the full article, register now.
Already a subscriber? Click here to view full article